Atrys Health, S.A. (ATRY.MC)
EUR 2.88
(1.77%)
EUR 2.88
(1.77%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.60 EUR | -76.47% |
| 2022 | -0.34 EUR | 20.93% |
| 2021 | -0.43 EUR | -503.93% |
| 2020 | -0.07 EUR | -1353.06% |
| 2019 | -0.00 EUR | -916.67% |
| 2018 | 0.00 EUR | -97.78% |
| 2017 | 0.03 EUR | 365.52% |
| 2016 | 0.01 EUR | -96.38% |
| 2015 | 0.16 EUR | 305.06% |
| 2014 | 0.04 EUR | -4.82% |
| 2013 | 0.04 EUR | -50.6% |
| 2012 | 0.08 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.11 EUR | 63.33% |
| 2024 Q2 | -0.11 EUR | 0.0% |
| 2023 Q1 | -0.09 EUR | 66.81% |
| 2023 Q4 | -0.30 EUR | -172.73% |
| 2023 FY | - EUR | -76.47% |
| 2023 Q3 | -0.11 EUR | 63.33% |
| 2023 Q2 | -0.30 EUR | -247.62% |
| 2022 Q2 | -0.05 EUR | -130.14% |
| 2022 FY | - EUR | 20.93% |
| 2022 Q3 | -0.15 EUR | -197.62% |
| 2022 Q1 | -0.02 EUR | 93.36% |
| 2022 Q4 | -0.26 EUR | -73.33% |
| 2021 Q4 | -0.33 EUR | -106.25% |
| 2021 Q2 | -0.08 EUR | -78.53% |
| 2021 Q3 | -0.16 EUR | -88.68% |
| 2021 FY | - EUR | -503.93% |
| 2021 Q1 | -0.05 EUR | 33.0% |
| 2020 FY | - EUR | -1353.06% |
| 2020 Q2 | -0.02 EUR | 0.0% |
| 2020 Q1 | -0.02 EUR | -137.36% |
| 2020 Q3 | -0.07 EUR | -228.24% |
| 2020 Q4 | -0.07 EUR | 0.0% |
| 2019 Q4 | -0.01 EUR | -68.52% |
| 2019 Q2 | 0.01 EUR | 96.67% |
| 2019 Q3 | -0.01 EUR | -191.53% |
| 2019 Q1 | 0.00 EUR | 128.85% |
| 2019 FY | - EUR | -916.67% |
| 2018 Q1 | 0.01 EUR | 42.22% |
| 2018 FY | - EUR | -97.78% |
| 2018 Q4 | -0.01 EUR | -85.71% |
| 2018 Q3 | -0.01 EUR | -144.09% |
| 2018 Q2 | 0.01 EUR | 98.44% |
| 2017 Q4 | 0.00 EUR | 0.0% |
| 2017 FY | - EUR | 365.52% |
| 2017 Q2 | 0.01 EUR | 0.0% |
| 2017 Q1 | 0.01 EUR | 157.14% |
| 2017 Q3 | 0.00 EUR | -48.86% |
| 2016 Q1 | 0.02 EUR | 0.0% |
| 2016 Q2 | 0.02 EUR | 0.0% |
| 2016 FY | - EUR | -96.38% |
| 2016 Q4 | -0.02 EUR | 0.0% |
| 2016 Q3 | -0.02 EUR | -162.86% |
| 2015 FY | - EUR | 305.06% |
| 2014 FY | - EUR | -4.82% |
| 2013 FY | - EUR | -50.6% |
| 2012 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biotechnologies Assets SA | 0.03 EUR | 2297.802% |
| Oryzon Genomics S.A. | -0.06 EUR | -988.929% |
| Pharma Mar, S.A. | 0.06 EUR | 1044.882% |
| Laboratorios Farmaceuticos Rovi, S.A. | 3.29 EUR | 118.237% |